Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibility

6 Apr 2021

Abstract excerpt

Human pathogenic RNA viruses are threats to public health because they are prone to escaping the human immune system through mutations of genomic RNA, thereby causing local outbreaks and global pandemics of emerging or re-emerging viral diseases. While specific therapeutics and vaccines are being developed, a broad-spectrum therapeutic agent for RNA viruses would be beneficial for targeting newly emerging and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33822489
DOI: 10.1002/2211-5463.13153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

iPSC screening for drug repurposing identifies anti‐RNA virus agents modulating host cell susceptibilityPMID 33822489Read ↗

Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2Semantic proximity Read ↗

Comparative Analysis of Molecular Pathogenic Mechanisms and Antiviral Development Targeting Old and New World HantavirusesSemantic proximity Read ↗

Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySemantic proximity Read ↗

Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2Semantic proximity Read ↗

Drug Repurposing Approach Identifies Inhibitors of the Prototypic Viral Transcription Factor IE2 that Block Human Cytomegalovirus ReplicationSemantic proximity Read ↗

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read ↗

Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral ActivitySemantic proximity Read ↗

Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screeningSemantic proximity Read ↗

Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitroSemantic proximity Read ↗

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ParamyxovirusesSemantic proximity Read ↗

Establishment and Evaluation of Human iPS Cell-Derived Myeloid Cell Lines Susceptible to SARS-CoV-2.Semantic proximity Read ↗

Plant-derived epi-nutraceuticals as Potential Broad-Spectrum Anti-Viral AgentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.